AAO Digital GUIDELINES Apps (free trial)

Conjunctivitis

AAO GUIDELINES App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/566168

Contents of this Issue

Navigation

Page 27 of 33

Management 26 Table 7. Systemic Antibiotic Therapy for Gonococcal and Chlamydial Conjunctivitis Cause Drug of Choice (Dosage) Adults Gonococcus a Ceriaxone b (250 mg IM, single dose) and Azithromycin (1 g orally, single dose) OR Doxycycline (100 mg orally, twice a day for 7 days) For cephalosporin-allergic patients: Azithromycin c (2 g orally, single dose) Chlamydia d Azithromycin (1 g orally, single dose ) OR Doxycycline (100 mg orally twice a day for 7 days) Children e (<18 years) Gonococcus Children who weigh <45 kg Ceriaxone (125 mg IM, single dose) OR Spectinomycin f (40 mg/kg (maximum dose 2 g ) IM, single dose) Children who weigh ≥45 kg Same treatment as adults Chlamydia Children who weigh <45 kg Erythromycin base or ethylsuccinate (50 mg/kg/day orally divided into 4 doses daily for 14 days) Children who weigh ≥45 kg but are aged <8 years Azithromycin (1 g orally, single dose) Children ≥8 years Azithromycin (1 g orally, single dose) OR Doxycycline (100 mg orally, twice daily for 7 days) Neonates Ophthalmia neonatorum caused by N. gonorrhoeae Ceriaxone (25–50 mg/kg intravenous or IM, single dose, not to exceed 125 mg ) Chlamydia Erythromycin base or ethylsuccinate (50 mg/kg/day orally divided into four doses daily for 14 days g )

Articles in this issue

Archives of this issue

view archives of AAO Digital GUIDELINES Apps (free trial) - Conjunctivitis